Loren L Flynn

5PUBLICATIONS
13CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesMedical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 10, 2024
Allele-Selective Thiomorpholino Antisense Oligonucleotides as a Therapeutic Approach for Fused-in-Sarcoma Amyotrophic Lateral Sclerosis.

Rita Mejzini, Marvin H Caruthers, Balazs Schafer

|Aug 26, 2022
Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Bradley Roberts, Frances Theunissen, Francis L Mastaglia

|Jun 02, 2021
Targeted SMN Exon Skipping: A Useful Control to Assess In Vitro and In Vivo Splice-Switching Studies.

Loren L Flynn, Chalermchai Mitrpant, Abbie Adams

|Aug 06, 2020
Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort.

Julia Pytte, Loren L Flynn, Ryan S Anderton

|Oct 17, 2019
Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides.

May T Aung-Htut, Craig S McIntosh, Kristin A Ham

Pageof 1

Frequent Collaborators

1 joint publications

May T Aung-Htut

1 joint publications

Craig S McIntosh

1 joint publications

Julia Pytte

1 joint publications

Ryan S Anderton